These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11578499)

  • 41. [Significance and implication on changes of serum squamous cell carcinoma antigen in the diagnosis of recurrence squamous cell carcinoma of cervix].
    Li Q; Liu S; Liu H; Zhang J; Guo S; Wang L
    Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):131-6. PubMed ID: 25877611
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Early-stage cervical cancer: agreement between ultrasound and histopathological findings with regard to tumor size and extent of local disease.
    Gaurilcikas A; Vaitkiene D; Cizauskas A; Inciura A; Svedas E; Maciuleviciene R; Di Legge A; Ferrandina G; Testa AC; Valentin L
    Ultrasound Obstet Gynecol; 2011 Dec; 38(6):707-15. PubMed ID: 21538643
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The uses and limitations of DNA flow cytometry in stage IB or II cervical carcinoma.
    Lai CH; Hsueh S; Huang MY; Chang MF; Soong YK
    Cancer; 1993 Dec; 72(12):3655-62. PubMed ID: 8252482
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Risk factors and prognosis of node-positive cervical carcinoma].
    Feng SY; Zhang YN; Liu JG
    Ai Zheng; 2005 Oct; 24(10):1261-6. PubMed ID: 16219145
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical staging and histopathological findings after radical hysterectomy in FIGO stage IIB cervical cancer.
    Mandic A; Novakovic P; Mihajlovic O; Stojiljkovic B; Rajovic J; Davidovic M
    J BUON; 2008; 13(1):51-4. PubMed ID: 18404786
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic factors in FIGO stage IB cervical cancer without lymph node metastasis and the role of adjuvant radiotherapy after radical hysterectomy.
    Ayhan A; Al RA; Baykal C; Demirtas E; Ayhan A; Yüce K
    Int J Gynecol Cancer; 2004; 14(2):286-92. PubMed ID: 15086728
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Laterally extended parametrectomy in cases with cervical carcinoma].
    Slavchev B; Markov P; Slavov S
    Akush Ginekol (Sofiia); 2011; 50(5):24-30. PubMed ID: 22482157
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The prognostic significance of the minimum thickness of uninvolved cervix in patients with cervical carcinoma stages IB, IIA, and IIB.
    Inoue T; Casanova HA; Morita K; Chihara T
    Gynecol Oncol; 1986 Jun; 24(2):220-9. PubMed ID: 3086192
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Changes in the demographics and perioperative care of stage IA(2)/IB(1) cervical cancer over the past 16 years.
    Covens A; Rosen B; Murphy J; Laframboise S; DePetrillo AD; Lickrish G; Colgan T; Chapman W; Shaw P
    Gynecol Oncol; 2001 May; 81(2):133-7. PubMed ID: 11330939
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cervical cancer: combined modality therapy.
    Grigsby PW
    Cancer J; 2001; 7 Suppl 1():S47-50. PubMed ID: 11504285
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Resection of the embryologically defined uterovaginal (Müllerian) compartment and pelvic control in patients with cervical cancer: a prospective analysis.
    Höckel M; Horn LC; Manthey N; Braumann UD; Wolf U; Teichmann G; Frauenschläger K; Dornhöfer N; Einenkel J
    Lancet Oncol; 2009 Jul; 10(7):683-92. PubMed ID: 19482513
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A comparison of laparoscopic radical hysterectomy and pelvic lymphadenectomy and laparotomy in the treatment of Ib-IIa cervical cancer.
    Li G; Yan X; Shang H; Wang G; Chen L; Han Y
    Gynecol Oncol; 2007 Apr; 105(1):176-80. PubMed ID: 17197013
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pre-operative MR evaluation of features that indicate the need of adjuvant therapies in early stage cervical cancer patients. A single-centre experience.
    Rizzo S; Calareso G; Maccagnoni S; Angileri SA; Landoni F; Raimondi S; Pasquali E; Lazzari R; Bellomi M
    Eur J Radiol; 2014 May; 83(5):858-64. PubMed ID: 24581810
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment outcomes in patients with FIGO stage IB-IIA cervical cancer and a focally disrupted cervical stromal ring on magnetic resonance imaging: A propensity score matching study.
    Kong TW; Lee JD; Son JH; Paek J; Chun M; Chang SJ; Ryu HS
    Gynecol Oncol; 2016 Oct; 143(1):77-82. PubMed ID: 27423377
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Is radical hysterectomy necessary in early cervical cancer?
    Meirovitz M; Sade S; Dreiher J; Shaco-Levy R
    Gynecol Obstet Invest; 2013; 76(3):158-62. PubMed ID: 24051740
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clear cell carcinoma of the uterine cervix: pathology and prognosis in surgically treated stage IB-IIB disease in women not exposed in utero to diethylstilbestrol.
    Reich O; Tamussino K; Lahousen M; Pickel H; Haas J; Winter R
    Gynecol Oncol; 2000 Mar; 76(3):331-5. PubMed ID: 10684706
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lymph node metastases and prognosis in patients with stage IA2 cervical cancer.
    Buckley SL; Tritz DM; Van Le L; Higgins R; Sevin BU; Ueland FR; DePriest PD; Gallion HH; Bailey CL; Kryscio RJ; Fowler W; Averette H; van Nagell JR
    Gynecol Oncol; 1996 Oct; 63(1):4-9. PubMed ID: 8898159
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Risk factors of pelvic lymph node metastasis in cervical adenocarcinoma following radical hysterectomy and pelvic lymphadenectomy.
    Yanaranop M; Sathapornteera N; Nakrangsee S
    J Med Assoc Thai; 2014 Nov; 97 Suppl 11():S87-95. PubMed ID: 25509701
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Surgical pathologic factors that predict recurrence in stage IB and IIA cervical carcinoma patients with negative pelvic lymph nodes.
    Samlal RA; van der Velden J; Ten Kate FJ; Schilthuis MS; Hart AA; Lammes FB
    Cancer; 1997 Oct; 80(7):1234-40. PubMed ID: 9317173
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Twelve years experience with radical hysterectomy and pelvic lymphadenectomy in early stage cervical cancer.
    Suprasert P; Srisomboon J; Charoenkwan K; Siriaree S; Cheewakriangkrai C; Kietpeerakool C; Phongnarisorn C; Sae-Teng J
    J Obstet Gynaecol; 2010 Apr; 30(3):294-8. PubMed ID: 20373935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.